IBA Worldwide

IBA develops, manufactures and supports medical devices and software solutions for cancer treatment by proton beam therapy.

Launch date

1986

Employees

1001-5000 people

Market cap

Enterprise valuation

AUD666m (Public information from Sep 2024)

Ottignies-Louvain-la-Neuve Walloon Brabant (HQ)

http://www.iba-worldwide.com

https://twitter.com/ibaworldwide https://www.facebook.com/pages/Ion-Beam-Applications/109637382413246 https://www.linkedin.com/company/iba-proton-therapy

View job openings

Revenues, earnings & profits over time

EUR	2019	2020	2021	2022	2023	2024	2025
Revenues	283m	312m	313m	361m	429m	454m	512m
% growth	36 %	10 %	-	15 %	19 %	6 %	13 %
EBITDA	14.7m	46.7m	25.9m	18.9m	16.5m	-	-
% EBITDA margin	5 %	15 %	8 %	5 %	4 %	-	-
Profit	7.6m	31.9m	3.9m	6.1m	(9.1m)	-	-
% profit margin	3 %	10 %	1 %	2 %	(2 %)	-	-
R&D budget	31.1m	33.1m	34.0m	41.8m	47.9m	-	-
R&D % of revenue	11 %	11 %	11 %	12 %	11 %	-	-

Source: Dealroom estimates

Date	Investors	Amount	Round
Jun 1999	N/A	N/A	IPO
Total Funding		-

Radcal Corporation

ACQUISITION by IBA Worldwide Feb 2024

Modus Medical Devices

ACQUISITION by IBA Worldwide May 2022